400 related articles for article (PubMed ID: 10684291)
21. [Superantigens and retroviral infections. Increase of mammary tumorigenicity due to recombination between exogenous and endogenous MMTV viruses].
Nepomnaschy I; Buggiano V; Goldman A; Deroche A; Bekinschtein P; Berguer P; Piazzon I
Medicina (B Aires); 1997; 57(3):327-31. PubMed ID: 9640768
[TBL] [Abstract][Full Text] [Related]
22. Mouse mammary tumor virus: a virus that exploits the immune system.
Bramblett D; Liu J; Lozano M; Xu L; Wrona T; Rajan L; Ross SR; Dudley J
Leukemia; 1997 Apr; 11 Suppl 3():183-6. PubMed ID: 9209337
[TBL] [Abstract][Full Text] [Related]
23. Mouse mammary tumor virus and mammary tumorigenesis in wild mice.
Imai S
Pathol Int; 1996 Dec; 46(12):919-32. PubMed ID: 9110343
[TBL] [Abstract][Full Text] [Related]
24. Molecular and cellular basis of the retrovirus resistance in I/LnJ mice.
Case LK; Purdy A; Golovkina TV
J Immunol; 2005 Dec; 175(11):7543-9. PubMed ID: 16301663
[TBL] [Abstract][Full Text] [Related]
25. Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance.
Schirrmacher V; Beutner U; Bucur M; Umansky V; Rocha M; von Hoegen P
J Immunol; 1998 Jul; 161(2):563-70. PubMed ID: 9670928
[TBL] [Abstract][Full Text] [Related]
26. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus.
Held W; Waanders GA; MacDonald HR; Acha-Orbea H
Int Immunol; 1994 Sep; 6(9):1403-7. PubMed ID: 7819149
[TBL] [Abstract][Full Text] [Related]
27. Mouse mammary tumor virus proviral sequences congenital to C3H/Sm mice are differentially hypomethylated in chemically induced, virus-induced, and spontaneous mammary tumors.
Drohan WN; Benade LE; Graham DE; Smith GH
J Virol; 1982 Sep; 43(3):876-84. PubMed ID: 6292467
[TBL] [Abstract][Full Text] [Related]
28. A highly sensitive in vitro infection assay to explore early stages of mouse mammary tumor virus infection.
Vacheron S; Renno T; Acha-Orbea H
J Virol; 1997 Oct; 71(10):7289-94. PubMed ID: 9311804
[TBL] [Abstract][Full Text] [Related]
29. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
Palmer LD; Saha B; Hodes RJ; Abe R
J Immunol; 1996 Mar; 156(6):2112-8. PubMed ID: 8690899
[TBL] [Abstract][Full Text] [Related]
30. Expression of a MHC class II transgene determines both superantigenicity and susceptibility to mammary tumor virus infection.
Pucillo C; Cepeda R; Hodes RJ
J Exp Med; 1993 Oct; 178(4):1441-5. PubMed ID: 8397273
[TBL] [Abstract][Full Text] [Related]
31. Neonatal infection with a milk-borne virus is independent of beta7 integrin- and L-selectin-expressing lymphocytes.
Czarneski J; Berguer P; Bekinschtein P; Kim DC; Hakimpour P; Wagner N; Nepomnaschy I; Piazzon I; Ross SR
Eur J Immunol; 2002 Apr; 32(4):945-56. PubMed ID: 11920560
[TBL] [Abstract][Full Text] [Related]
32. Expression of mouse mammary tumor virus envelope protein does not prevent superinfection in vivo or in vitro.
Dzuris JL; Zhu W; Kapkov D; Golovkina TV; Ross SR
Virology; 1999 Oct; 263(2):418-26. PubMed ID: 10544114
[TBL] [Abstract][Full Text] [Related]
33. Mouse mammary tumor virus (MMTV) infection in SWISS and RIII mice. Correlation between resistance to exogenous infection and anti-MMTV serum response.
Hainaut P; Vaira D; Francois C; Calberg-Bacq CM
Arch Virol; 1990; 113(1-2):35-52. PubMed ID: 2167058
[TBL] [Abstract][Full Text] [Related]
34. Characterization of two infectious mouse mammary tumour viruses: superantigenicity and tumorigenicity.
Buggiano V; Goldman A; Nepomnaschy I; Bekinschtein P; Berguer P; Lombardi G; Deroche A; Francisco MV; Piazzon I
Scand J Immunol; 1999 Mar; 49(3):269-77. PubMed ID: 10102644
[TBL] [Abstract][Full Text] [Related]
35. Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection.
Okeoma CM; Petersen J; Ross SR
J Virol; 2009 Apr; 83(7):3029-38. PubMed ID: 19153233
[TBL] [Abstract][Full Text] [Related]
36. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
Hodes RJ; Novick MB; Palmer LD; Knepper JE
J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
[TBL] [Abstract][Full Text] [Related]
37. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus.
Held W; Shakhov AN; Izui S; Waanders GA; Scarpellino L; MacDonald HR; Acha-Orbea H
J Exp Med; 1993 Feb; 177(2):359-66. PubMed ID: 8093892
[TBL] [Abstract][Full Text] [Related]
38. Mouse mammary tumor virus and the immune system.
Czarneski J; Rassa JC; Ross SR
Immunol Res; 2003; 27(2-3):469-80. PubMed ID: 12857990
[TBL] [Abstract][Full Text] [Related]
39. Superantigens of mouse mammary tumor virus.
Acha-Orbea H; MacDonald HR
Annu Rev Immunol; 1995; 13():459-86. PubMed ID: 7612231
[TBL] [Abstract][Full Text] [Related]
40. A novel block to mouse mammary tumor virus infection of lymphocytes in B10.BR mice.
Okeoma CM; Shen M; Ross SR
J Virol; 2008 Feb; 82(3):1314-22. PubMed ID: 18003725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
